To the Editor: The diagnosis of a new Lyme disease infectionby conventional assays may be difficult in persons who haveantibodies to or immunologic memory of Borrelia burgdorferiproteins. This was the case in a recipient of vaccine containingrecombinant outer-surface protein A (OspA) of B. burgdorferi(Connaught).1 Analysis of the antibody and antigen constituentsof B. burgdorferispecific immune complexes can distinguishbetween past and active infection in such patients.2,3
Several years before vaccination, a woman with Lyme diseasedocumented by the presence of erythema migrans and by a positivepolymerase-chain-reaction assay of a skin-biopsy specimen wassuccessfully . . . [Full Text of this Article]
References
This article has been cited by other articles:
Wieneke, C. A., Lovrich, S. D., Callister, S. M., Jobe, D. A., Marks, J. A., Schell, R. F.
(2000). Evaluation of Whole-Cell and OspC Enzyme-Linked Immunosorbent Assays for Discrimination of Early Lyme Borreliosis from OspA Vaccination. J. Clin. Microbiol.
38: 313-317
[Abstract][Full Text]
Schutzer, S. E., Coyle, P. K., Reid, P., Holland, B.
(1999). Borrelia burgdorferi-Specific Immune Complexes in Acute Lyme Disease. JAMA
282: 1942-1946
[Abstract][Full Text]
Jensen, J. R., Du Chateau, B. K., Munson, E. L., Callister, S. M., Schell, R. F.
(1998). Inhibition of the Production of Anti-OspA Borreliacidal Antibody with T Cells from Hamsters Vaccinated against Borrelia burgdorferi. Infect. Immun.
66: 1507-1512
[Abstract][Full Text]